Skip to content


Volume 17 Supplement 4

Sepsis 2013

  • Poster presentation
  • Open Access

Evaluation of the cardiac effects of norepinephrine and dobutamine in rats with septic shock

  • 1,
  • 1 and
  • 1
Critical Care201317 (Suppl 4) :P80

  • Published:


  • Norepinephrine
  • Septic Shock
  • Hypoglycemia
  • Severe Sepsis
  • Dobutamine


Hypotension and cardiac dysfunction are frequently found in severe sepsis and septic shock. Vasoactive and inotropic drugs are largely used to reverse hypotension, but its effects on heart function have been scarcely investigated [1]. We thus evaluated the influence of both norepinephrine and dobutamine on the cardiovascular function of rats subjected to cecal ligation and puncture (CLP).

Materials and methods

The measurement of the cardiac function was performed in male Wistar rats (3 to 4 months old), kept under isoflurane-induced anesthesia (1 to 3%), using a pressure-volume catheter, which was inserted into the left ventricle through the carotid artery. Blood samples were collected from all animals for hematological analyses. The experiments were conducted at 24 and 48 hours after CLP. For this, the cecum was ligated with a ratio of 50% and perforated with a needle (18 G, four holes; mortality rate ~50% after 48 hours), followed by four subcutaneous injections (12/12 hours) of sterile saline (30 ml/kg) and tramadol (5 mg/kg), for fluid resuscitation and analgesia, respectively. Data were recorded at baseline and after single bolus administration of norepinephrine (1, 3 and 10 nmol/kg, i.v.) or dobutamine (3, 10 and 30 nmol/kg, i.v.). The results obtained in CLP groups were compared with control (CT) animals, which did not undergo any manipulation.


Both CLP 24 and 48 hour groups presented thrombocytopenia (~40% reduction), lymphopenia, hypoglycemia and leukopenia (P < 0.05), a clear indication of severe sepsis. However, only CLP 48 hour animals displayed refractory hypotension (MAP = 59 mmHg, vs. 78 mmHg in CT; P < 0.05) in spite of volume resuscitation. The highest doses of norepinephrine and dobutamine increased the MAP to 133.8 ± 8.1 and 97.8 ± 3.1 mmHg in CT, and to 120.6 ± 6.7 and 77.3 ± 4.4 mmHg in CLP 48 hour animals, respectively. The heart rate was significantly increased by norepinephrine and dobutamine in control, but not in CLP 48 hour animals. In addition, the basal values of both dP/dtmax and dP/dtmin, as well as after 1 nmol/kg dobutamine, were reduced in CLP 48 hour animals.


Using a pressure-volume catheter in a closed-chest approach we demonstrated that, in spite of the ability to increase blood pressure, the chronotropic effects of norepinephrine and dobutamine are reduced at 48 hours after CLP in rats subjected to CLP. In addition, all doses of norepinephrine, but only by the highest doses of dobutamine, improved systolic and diastolic function in these animals.



CNPq and FAPESC (2012000367 and 2012000078).

Authors’ Affiliations

Department of Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, Brazil


  1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39: 165-228. 10.1007/s00134-012-2769-8View ArticlePubMedGoogle Scholar


© Goncalves et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.